131 related articles for article (PubMed ID: 33711200)
1. Inhibitory Effect of Eugenol and trans-Anethole Alone and in Combination with Antifungal Medicines on Candida albicans Clinical Isolates.
Dąbrowska M; Zielińska-Bliźniewska H; Kwiatkowski P; Łopusiewicz Ł; Pruss A; Kostek M; Kochan E; Sienkiewicz M
Chem Biodivers; 2021 May; 18(5):e2000843. PubMed ID: 33711200
[TBL] [Abstract][Full Text] [Related]
2. Improved efficacy of eugenol and
Dąbrowska M; Zielińska-Bliźniewska H; Kwiatkowski P; Guenther S; Łopusiewicz Ł; Kochan E; Pruss A; Sienkiewicz M
Ann Agric Environ Med; 2023 Mar; 30(1):204-210. PubMed ID: 36999876
[TBL] [Abstract][Full Text] [Related]
3. Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans.
Braga PC; Sasso MD; Culici M; Alfieri M
Fitoterapia; 2007 Sep; 78(6):396-400. PubMed ID: 17590533
[TBL] [Abstract][Full Text] [Related]
4. Antifungal Activity of Eugenol Loaded Electrospun PAN Nanofiber Mats Against Candida Albicans.
Semnani K; Shams-Ghahfarokhi M; Afrashi M; Fakhrali A; Semnani D
Curr Drug Deliv; 2018; 15(6):860-866. PubMed ID: 29484994
[TBL] [Abstract][Full Text] [Related]
5. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
Khan MS; Ahmad I
J Antimicrob Chemother; 2012 Mar; 67(3):618-21. PubMed ID: 22167241
[TBL] [Abstract][Full Text] [Related]
6. Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
Kubo I; Muroi H; Himejima M
J Nat Prod; 1993 Feb; 56(2):220-6. PubMed ID: 8463795
[TBL] [Abstract][Full Text] [Related]
7. Alkylphenol Activity against Candida spp. and Microsporum canis: A Focus on the Antifungal Activity of Thymol, Eugenol and O-Methyl Derivatives.
Fontenelle RO; Morais SM; Brito EH; Brilhante RS; Cordeiro RA; Lima YC; Brasil NV; Monteiro AJ; Sidrim JJ; Rocha MF
Molecules; 2011 Jul; 16(8):6422-31. PubMed ID: 25134762
[TBL] [Abstract][Full Text] [Related]
8. Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids.
Khan A; Ahmad A; Akhtar F; Yousuf S; Xess I; Khan LA; Manzoor N
FEMS Yeast Res; 2011 Feb; 11(1):114-22. PubMed ID: 21114624
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans.
Jafri H; Khan MSA; Ahmad I
Phytomedicine; 2019 Feb; 54():206-213. PubMed ID: 30668370
[TBL] [Abstract][Full Text] [Related]
10. Synergistic fungicidal activity with low doses of eugenol and amphotericin B against Candida albicans.
Khan SN; Khan S; Misba L; Sharief M; Hashmi A; Khan AU
Biochem Biophys Res Commun; 2019 Oct; 518(3):459-464. PubMed ID: 31443962
[TBL] [Abstract][Full Text] [Related]
11. Cellular apoptosis and necrosis as therapeutic targets for novel Eugenol Tosylate Congeners against Candida albicans.
Lone SA; Wani MY; Fru P; Ahmad A
Sci Rep; 2020 Jan; 10(1):1191. PubMed ID: 31988394
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans.
Boonchird C; Flegel TW
Can J Microbiol; 1982 Nov; 28(11):1235-41. PubMed ID: 6758923
[TBL] [Abstract][Full Text] [Related]
13.
Shahina Z; Ndlovu E; Persaud O; Sultana T; Dahms TES
Microbiol Spectr; 2022 Dec; 10(6):e0318322. PubMed ID: 36394350
[TBL] [Abstract][Full Text] [Related]
14. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin.
Doke SK; Raut JS; Dhawale S; Karuppayil SM
J Gen Appl Microbiol; 2014; 60(5):163-8. PubMed ID: 25420420
[TBL] [Abstract][Full Text] [Related]
16. Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.
Tariq VN; Scott EM; McCain NE
Antimicrob Agents Chemother; 1995 Dec; 39(12):2615-9. PubMed ID: 8592989
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of novel Eugenol Tosylate Congeners on pathogenicity of Candida albicans.
Lone SA; Ahmad A
BMC Complement Med Ther; 2020 Apr; 20(1):131. PubMed ID: 32349730
[TBL] [Abstract][Full Text] [Related]
19. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans.
Ahmad A; Wani MY; Khan A; Manzoor N; Molepo J
PLoS One; 2015; 10(12):e0145053. PubMed ID: 26694966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
